skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » UK Shares » AIM Risers and Fallers » AIM round-up: Mysale Group, Kefi Gold, Tower Resources

It’s been another bruising session for London’s AIM Index with the market falling almost sixteen points or close on 2% to reach 877.35 by the bell, representing levels not seen in almost two years.

  • Mysale Group +44%
  • Kefi Gold +32%
  • Tower Resources +16%
  • Cornerstone -56%
  • Shield Therapeutics -40%

Mysale Group [LON:MYSL] topped the board, up 46% by the bell although close on half of this was accounted for by the spread. Orders were thin on the ground and there’s no news here but this small cap stock valued at just £16m has been no stranger to erratic price moves in recent months.

Kefi Gold [LON:KEFI] also fared well, adding 35% by the bell. This morning the company announced the signing of an umbrella financing agreement regarding its Ethiopian project, followed by news that all its AGM resolutions had been passed. However this move only recovers losses from the last couple of months – is there more upside to be had?

A notable mention for Tower Resources [LON:TRP], up 16% by 4.30pm. Last night the company released a financing update driving sharp gains at the open then early this afternoon announced all its AGM resolutions had also been passed in its favour to an admittedly more muted response.

Cornerstone [LON:CSFS] was the day’s laggard, off 56% at the bell in the wake of its full year results being published this morning. Whilst the note strikes an upbeat tone, it also flags the fact that losses continue to grow off the back of rising admin costs and that there’s less than £300k in the bank account. With this in mind an equity raise in the coming months is seen as inevitable.

Shield Therapeutics [LON:STX] also struggled, off 40% on the day. A business update, final results and financing update were all provided this morning. Critically a major shareholder has provided a loan for $10m to the company, following the failure of earlier attempts to tap the market for $30m. Given the market cap of £16m – so around $20m – this funding is significant, especially if subsequent moves to flip the debt into equity are realised.


This article is not investment advice. Investors should do their own research or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we follow most closely. They represent significant growth stories in our view. Our in-depth reports detail why we like them.


Subscribe for more stories like this, 8am weekdays - for free!

Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Back To Top